BioMarin to Participate in 2019 RBC Capital Markets Global Healthcare Conference on May 21 in New York City

SAN RAFAEL, Calif., May 16, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Robert Baffi, Ph.D., Executive Vice President, Technical Operations, will participate in a gene therapy manufacturing focused fireside chat at the RBC Capital Markets Global Healthcare Conference on May 21 at 8:00am ET in New York City. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of several commercial products and multiple clinical and pre-clinical product candidates for the treatment of various diseases. For additional information, please visit www.biomarin.com.

     Contacts:



     Investors                              
     Media


                Traci McCarty                
     
         Debra Charlesworth


                BioMarin Pharmaceutical Inc.         BioMarin Pharmaceutical Inc.


                (415) 455-7558               
     
         (415) 455-7451

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-2019-rbc-capital-markets-global-healthcare-conference-on-may-21-in-new-york-city-300851391.html

SOURCE BioMarin Pharmaceutical Inc.